Evidence map›Paper›PMID 32587669›Full record

ArticleFrontline gastroenterology2020

Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia.

Durayd Alzoubaidi, Krish Ragunath, Sachin Wani, Ian D Penman, Nigel John Trudgill, Marnix Jansen, Matthew Banks, Pradeep Bhandari, Allan John Morris, Robert Willert and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontline gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Durayd AlzoubaidiDivision of Surgery and Interventional Science, University College London (UCL), London, UK.ORCID 0000-0001-8308-1667
Krish RagunathDepartment of Gastroenterology, Queens Medical Centre, University Hospital Nottingham, Nottingham, UK.
Sachin WaniDivision of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Ian D PenmanGastrointestinal Unit, Western General Hospital, Edinburgh, UK.ORCID 0000-0003-0785-6744
Nigel John TrudgillGastroenterology, Sandwell General Hospital, West Bromwich, UK.
Marnix JansenDepartment of Histopathology, University College London Hospital, London, UK.
Matthew BanksDepartment of Gastroenterology, University College London Hospital, London, UK.
Pradeep BhandariDepartment of Gastroenterology, Queen Alexandra Hospital Portsmouth, Portsmouth, UK.ORCID 0000-0002-1241-2083
Allan John MorrisDepartment of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.
Robert WillertDepartment of Gastroenterology, Manchester Royal Infirmary, Manchester, UK.
Phil BogerDepartment of Gastroenterology, University Hospital Southampton, Southampton, UK.
Howard L SmartDepartment of Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, Merseyside, UK.
Narayanasamy RaviDivision of Surgery, St James's Hospital, Dublin, Ireland.
Jason DunnDepartment of Gastroenterology, Guy's and St Thomas' Hospital, London, UK.
Charles GordonDepartment of Gastroenterology, Royal Bournemouth Hospital, Bournemouth, UK.
Jayan MannathDepartment of Gastroenterology, Coventry and Warwickshire NHS Trust, Coventry, UK.
Inder MainieDepartment of Gastroenterology, Belfast City Hospital, Belfast, UK.
Massi di PietroMRC Cancer Unit, University of Cambridge, Cambridge, UK.
Andrew M VeitchDepartment of Gastroenterology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.
Sally ThorpeDepartment of Gastroenterology, University Colleg London Hospital, London, UK.
Cormac MageeDepartment of Gastroenterology, University College London Hospital, Londons, UK.
Martin EversonDepartment of Gastroenterology, University Colleg London Hospital, London, UK.
Sarmed SamiDepartment of Gastroenterology, University Colleg London Hospital, London, UK.
Paul BassettStatsconsultancy, Amersham, UK.
David GrahamDepartment of Gastroenterology, University Colleg London Hospital, London, UK.
Stephen AttwoodDepartment of Health Services Research, Durham University, Durham, UK.
Oliver PechDepartment of Medicine, HSK Wiesbaden, Wiesbaden, Germany.
Prateek SharmaDepartment of Gastroenterology, University of Kansas, Kansas City, Kansas, USA.
Laurence B LovatDivision of Surgery and Interventional Science, University College London (UCL), Londons, UK.
Rehan HaidryDepartment of Gastroenterology and Division of Surgery and Interventional Science, University College London Hospitals NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEndoscopic therapy for the management of patients with Barrett's oesophagus (BE) neoplasia has significantly developed in the past decade; however, significant variation in clinical practice exists. The aim of this project was to develop expert physician-lead quality indicators (QIs) for Barrett's endoscopic therapy.

methodsThe RAND/UCLA Appropriateness Method was used to combine the best available scientific evidence with the collective judgement of experts to develop quality indicators for Barrett's endotherapy in four subgroups: pre-endoscopy, intraprocedure (resection and ablation) and postendoscopy. International experts, including gastroenterologists, surgeons, BE pathologist, clinical nurse specialist and patient representative, participated in a three-round process to develop 15 QIs that fulfilled the RAND/UCLA definition of appropriateness.

results17 experts participated in round 1 and 20 in round 2. Of the 24 proposed QIs in round 1, 20 were ranked as appropriate (put through to round 2) and 4 as uncertain (discarded). At the end of round 2, a final list of 15 QIs were scored as appropriate.

conclusionsThis UK national consensus project has successfully developed QIs for patients undergoing Barrett's endotherapy. These QIs can be used by service providers to ensure that all patients with BE neoplasia receive uniform and high-quality care.

Indexed as

Barrett’s OesophagusEndoscopic Mucosal Resection (EMR)Endoscopic Submucosal Dissection (ESD)endoscopyRadio Frequency Ablation (RFA)

Identifiers

PMID32587669
PMCPMC7307052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.